Ranitidine bismuth citrate-based triple therapy for seven days, with or without further anti-secretory therapy, is highly effective in patients with duodenal ulcer and Helicobacter pylori infection.
Objective: To compare the efficacy of two protocols for the eradication of Helicobacter pylori infection and the healing of active duodenal ulcer: (i) ranitidine bismuth citrate (RBC) plus two antibiotics for 7 days, and (ii) the same triple therapy followed by 3 weeks of anti-secretory drug treatme...
| Publicado en: | European Journal of Gastroenterology & Hepatology Vol. 13; no. 5; pp. 547 - 551 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , |
| Formato: | clinical trial research tables/charts Journal Article |
| Publicado: |
Lippincott Williams & Wilkins
2001 May
|
| Acceso en línea: | Ver este registro en EBSCOhost |